Results 321 to 330 of about 1,463,832 (396)

Nasopharyngeal carcinoma in childhood and adolescence

open access: bronze, 2000
Pedro Zubizarreta   +8 more
openalex   +1 more source

Potential Active Compounds of Ganoderma lucidum and Their Anticancer Effects: A Comprehensive Review

open access: yesFood Science &Nutrition, Volume 13, Issue 8, August 2025.
This paper systematically discusses various active compounds within Ganoderma lucidum and their application in the treatment of tumor diseases. ABSTRACT The incidence and mortality rates of cancer patients continue to rise. Although many physical and chemical therapies, such as targeted tumor treatments, are effective against cancer, they are often ...
Yuan Liu   +4 more
wiley   +1 more source

Prospective Registry Trial of Adjuvant High‐Dose Rate Brachytherapy in Unirradiated Head and Neck Cancer: 20‐Year Data

open access: yesHead &Neck, Volume 47, Issue 8, Page 2166-2173, August 2025.
ABSTRACT Background and Purpose Full‐dose postoperative external beam radiation therapy (EBRT)/chemoradiation is the standard of care in patients with resected, unirradiated head and neck cancer (HNC). This study aims to determine the long‐term results of adjuvant high‐dose rate (HDR) brachytherapy ± intermediate‐dose postoperative external beam ...
Alejandro García‐Consuegra   +10 more
wiley   +1 more source

Vision Changes After Head and Neck Cancer Treatment

open access: yesHead &Neck, Volume 47, Issue 8, Page 2192-2200, August 2025.
ABSTRACT Background Literature about ocular toxicity after head and neck cancer (HNC) treatment is scarce. This study aimed to describe visual function and ocular symptoms among HNC patients. Methods The study used a cross‐sectional design. Two surveys, The National Eye Institute Visual Functioning Questionnaire (NEI‐VFQ) and an Ocular Symptom Scale ...
Hsiao‐Lan Wang   +7 more
wiley   +1 more source

Loss of CDS1 impairs the tumorigenic characteristics of nasopharyngeal carcinoma by modulating lipid metabolism. [PDF]

open access: yesCell Adh Migr
Wang Y   +15 more
europepmc   +1 more source

Differences in PD‐L1, PD‐L2, and EGFR Expression Between Naive and Recurrent Tumors in Patients With Head and Neck Squamous Cell Carcinoma: A Retrospective Study

open access: yesHead &Neck, Volume 47, Issue 8, Page 2260-2269, August 2025.
ABSTRACT Background The efficacy of anti‐PD‐1 and EGFR therapies for head and neck squamous cell carcinoma (HNSCC) can be predicted using various markers; however, the stability of these markers remains unclear. Methods In this retrospective study, laboratory findings and tissue expression of PD‐L1, PD‐L2, and EGFR were analyzed in 79 paired naive and ...
Ryosuke Sato   +13 more
wiley   +1 more source

PLoS One [PDF]

open access: yes, 2012
Alles, J.   +11 more
core   +1 more source

Home - About - Disclaimer - Privacy